ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison

被引：18
作者：
Myllynen, Paivi [1 ]
Kummu, Maria [1 ,2 ]
Sieppi, Elina [1 ]
机构：
[1] Univ Oulu, Inst Biomed, Dept Pharmacol & Toxicol, FIN-90014 Oulu, Finland
[2] Univ Oulu, Ctr Arctic Med, Thule Inst, FIN-90014 Oulu, Finland
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2010年 / 6卷 / 11期
关键词：
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN EXPRESSION; LIMITS FETAL DISTRIBUTION; MULTIDRUG-RESISTANCE; PHOSPHOGLYCOPROTEIN ABCB1; DRUG TRANSPORTERS; GENE-EXPRESSION; MOUSE PLACENTA; RAT PLACENTA; BCRP/ABCG2;
D O I：
10.1517/17425255.2010.514264
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Areas covered in this review: Comprehensive literature searches were done using PubMed (until June 2010) to identify publications on ABCB1 and ABCG2 expression in placenta and fetal tissues in human, mouse, rat, guinea-pig and rabbit. What the reader will gain: In this review, we aim to provide an overview of the current knowledge on the ABCB1 and ABCG2 transporter expression profiles in the placenta and fetal tissues in humans relative to other species. Take home message: The available information on ABCB1 and ABCG2 temporal expression profiles in placenta and fetus indicates rather good correlation among human, mouse and rat although some specific differences have been reported. However, at this point no detailed comparisons or comparative functional data are available. Detailed knowledge on the expression patterns and functional activity of ABCB1 and ABCG2 transporters placenta and developing embryo/fetus in different species could possibly help the interspecies extrapolation.
引用
收藏
页码：1385 / 1398
页数：14
相关论文
共 50 条
  • [21] Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters
    Strouse, J. Jacob
    Ivnitski-Steele, Irena
    Waller, Anna
    Young, Susan M.
    Perez, Dominique
    Evangelisti, Annette M.
    Ursu, Oleg
    Bologa, Cristian G.
    Carter, Mark B.
    Salas, Virginia M.
    Tegos, George
    Larson, Richard S.
    Oprea, Tudor I.
    Edwards, Bruce S.
    Sklar, Larry A.
    ANALYTICAL BIOCHEMISTRY, 2013, 437 (01) : 77 - 87
  • [22] Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma
    Guo, Yuan-yuan
    Wu, Yuan
    Jia, Xiao-wei
    An, Wei
    LABORATORY INVESTIGATION, 2017, 97 (12) : 1400 - 1411
  • [23] Coexpression of ABCB1 and ABCG2 in a Cell Line Model Reveals Both Independent and Additive Transporter Function
    Robinson, Andrea N.
    Tebase, Bethelihem G.
    Francone, Sonia C.
    Huff, Lyn M.
    Kozlowski, Hanna
    Cossari, Dominique
    Lee, Jung-Min
    Esposito, Dominic
    Robey, Robert W.
    Gottesman, Michael M.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (07) : 715 - 723
  • [24] Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients
    Zhou, Yafang
    Wang, Xueding
    Li, Hongliang
    Zhang, Jie
    Chen, Ziyi
    Xie, Wen
    Zhang, Jinxin
    Li, Jiali
    Zhou, Liemin
    Huang, Min
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) : 282 - 287
  • [25] Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats
    Hammad, Alaa M.
    Alasmari, Fawaz
    Sari, Youssef
    Hall, F. Scott
    Tiwari, Amit K.
    MOLECULAR NEUROBIOLOGY, 2019, 56 (03) : 1921 - 1932
  • [26] Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2
    Wu, Chung-Pu
    Hsiao, Sung-Han
    Wu, Yu-Shan
    DRUG RESISTANCE UPDATES, 2023, 71
  • [27] Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance
    Bruhn, Oliver
    Cascorbi, Ingolf
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (10) : 1337 - 1354
  • [28] Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib
    Tournier, Nicolas
    Goutal, Sebastien
    Mairinger, Severin
    Hernandez-Lozano, Irene
    Filip, Thomas
    Sauberer, Michael
    Caille, Fabien
    Breuil, Louise
    Stanek, Johann
    Freeman, Anna F.
    Novarino, Gaia
    Truillet, Charles
    Wanek, Thomas
    Langer, Oliver
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (07) : 1634 - 1646
  • [29] Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513
    Salphati, Laurent
    Plise, Emile G.
    Li, Guangmin
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 37 (3-4) : 463 - 468
  • [30] Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation
    Lemmen, Julia
    Tozakidis, Iasson E. P.
    Bele, Prachee
    Galla, Hans-Joachim
    BRAIN RESEARCH, 2013, 1501 : 68 - 80
12345